• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌中铁死亡调控因子的研究进展(综述)。

Advances in the study of regulators of ferroptosis in head and neck squamous cell carcinoma (Review).

机构信息

Shanxi Medical University School and Hospital of Stomatology, Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Taiyuan, Shanxi 030001, P.R. China.

出版信息

Int J Mol Med. 2023 Jun;51(6). doi: 10.3892/ijmm.2023.5248. Epub 2023 Apr 13.

DOI:10.3892/ijmm.2023.5248
PMID:37052257
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10198043/
Abstract

Head and neck squamous cell carcinoma (HNSCC), a common malignancy of the head and neck, is associated with a rapid progression, a high mortality rate and unsatisfactory curative effects. The treatment efficacy is unsatisfactory due to chemotherapeutic drug resistance, the lack of ideal therapeutic agents, as well as the absence of clinical prognostic models. Thus, the identification of novel potential therapeutic targets for its diagnosis and treatment is vital. Ferroptosis is an iron‑dependent regulatory cell death mode different from traditional cell death modes, such as apoptosis and autophagy, and has notable therapeutic potential in cancer treatment. The study of ferroptosis in HNSCC is expected to solve this bottleneck problem. In the present review, the findings, characteristics and regulatory mechanisms of ferroptosis are summarized, with emphasis on the factors and drugs that regulate ferroptosis in HNSCC, in order to provide theoretical basis for the targeted therapy of ferroptosis in HNSCC.

摘要

头颈部鳞状细胞癌(HNSCC)是一种常见的头颈部恶性肿瘤,其具有快速进展、高死亡率和不理想的治疗效果等特点。由于化疗药物耐药性、缺乏理想的治疗药物以及缺乏临床预后模型,治疗效果并不令人满意。因此,鉴定新的潜在治疗靶点用于其诊断和治疗至关重要。铁死亡是一种不同于传统细胞死亡方式(如凋亡和自噬)的铁依赖性调节性细胞死亡方式,在癌症治疗中具有显著的治疗潜力。研究 HNSCC 中的铁死亡有望解决这一瓶颈问题。本综述总结了铁死亡的研究发现、特征和调控机制,重点介绍了调控 HNSCC 中铁死亡的因素和药物,以期为 HNSCC 的铁死亡靶向治疗提供理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/250c/10198043/4449d979aaaf/IJMM-51-6-05248-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/250c/10198043/7988cc5da1d6/IJMM-51-6-05248-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/250c/10198043/4449d979aaaf/IJMM-51-6-05248-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/250c/10198043/7988cc5da1d6/IJMM-51-6-05248-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/250c/10198043/4449d979aaaf/IJMM-51-6-05248-g01.jpg

相似文献

1
Advances in the study of regulators of ferroptosis in head and neck squamous cell carcinoma (Review).头颈部鳞状细胞癌中铁死亡调控因子的研究进展(综述)。
Int J Mol Med. 2023 Jun;51(6). doi: 10.3892/ijmm.2023.5248. Epub 2023 Apr 13.
2
Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.靶向FSP1通过脂质代谢驱动的铁死亡调节耐药持久性头颈癌细胞中的铁稳态。
Aging (Albany NY). 2024 Jan 10;16(1):627-647. doi: 10.18632/aging.205409.
3
Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.铁死亡相关的DNA甲基化特征可预测头颈部鳞状细胞癌患者的总生存期。
BMC Genomics. 2022 Jan 18;23(1):63. doi: 10.1186/s12864-022-08296-z.
4
Caveolin-1 promotes cancer progression via inhibiting ferroptosis in head and neck squamous cell carcinoma.窖蛋白-1 通过抑制头颈部鳞状细胞癌中的铁死亡促进癌症进展。
J Oral Pathol Med. 2022 Jan;51(1):52-62. doi: 10.1111/jop.13267. Epub 2021 Dec 19.
5
SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1.SENP1 通过调节 SUMO1 来稳定 ACSL4 蛋白,从而抑制铁死亡并促进头颈部鳞状细胞癌。
Oncol Rep. 2024 Feb;51(2). doi: 10.3892/or.2023.8693. Epub 2024 Jan 8.
6
HSPA5, as a ferroptosis regulator, may serve as a potential therapeutic for head and neck squamous cell carcinoma.HSPA5 作为铁死亡调控因子,可能成为头颈部鳞状细胞癌的潜在治疗靶点。
Mol Immunol. 2023 Jun;158:79-90. doi: 10.1016/j.molimm.2023.05.001. Epub 2023 May 10.
7
TP63 transcriptionally regulates SLC7A5 to suppress ferroptosis in head and neck squamous cell carcinoma.TP63 通过转录调控 SLC7A5 抑制头颈部鳞状细胞癌中的铁死亡。
Front Immunol. 2024 Aug 21;15:1445472. doi: 10.3389/fimmu.2024.1445472. eCollection 2024.
8
A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma.一种新的铁死亡相关基因签名,用于预测头颈部鳞状细胞癌患者的预后。
Dis Markers. 2021 Nov 22;2021:5759927. doi: 10.1155/2021/5759927. eCollection 2021.
9
A genome-wide CRISPR screen reveals that antagonism of glutamine metabolism sensitizes head and neck squamous cell carcinoma to ferroptotic cell death.全基因组 CRISPR 筛选揭示,谷氨酰胺代谢拮抗作用使头颈部鳞状细胞癌对铁死亡细胞死亡敏感。
Cancer Lett. 2024 Aug 28;598:217089. doi: 10.1016/j.canlet.2024.217089. Epub 2024 Jul 2.
10
Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.开发和验证一种新型的与铁死亡相关的基因特征,用于预测头颈部鳞状细胞癌的预后和免疫微环境。
Int Immunopharmacol. 2021 Sep;98:107789. doi: 10.1016/j.intimp.2021.107789. Epub 2021 Jun 12.

引用本文的文献

1
Integrating Multiomics and Machine Learning: Senescence-Regulated ALMS1-IT1/miR-7c-5p/HMGA2 Axis as a Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma.整合多组学与机器学习:衰老调控的ALMS1-IT1/miR-7c-5p/HMGA2轴作为头颈部鳞状细胞癌的新型治疗靶点
ACS Omega. 2025 Jul 1;10(27):28821-28835. doi: 10.1021/acsomega.4c11093. eCollection 2025 Jul 15.
2
Depletion of Effector Regulatory T Cells Associates with Major Response to Induction Dual Immune Checkpoint Blockade.效应调节性T细胞的耗竭与诱导双重免疫检查点阻断的主要反应相关。
Cancer Discov. 2025 Aug 4;15(8):1569-1592. doi: 10.1158/2159-8290.CD-24-1390.
3

本文引用的文献

1
Single cell RNA-seq analysis identifies ferroptotic chondrocyte cluster and reveals TRPV1 as an anti-ferroptotic target in osteoarthritis.单细胞 RNA 测序分析鉴定出铁死亡软骨细胞簇,并揭示 TRPV1 是骨关节炎中的一种抗铁死亡靶点。
EBioMedicine. 2022 Oct;84:104258. doi: 10.1016/j.ebiom.2022.104258. Epub 2022 Sep 19.
2
System X /GSH/GPX4 : An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy.系统X/谷胱甘肽/谷胱甘肽过氧化物酶4:耐药实体瘤治疗中细胞铁死亡的重要抗氧化系统。
Front Pharmacol. 2022 Aug 29;13:910292. doi: 10.3389/fphar.2022.910292. eCollection 2022.
3
Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1 potentiates cisplatin responsiveness in OSCC cells.
Ferroptosis-Related Gene Signatures: Prognostic Role in HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
铁死亡相关基因特征:在人乳头瘤病毒阳性口咽鳞状细胞癌中的预后作用
Cancers (Basel). 2025 Feb 5;17(3):530. doi: 10.3390/cancers17030530.
4
Integrated analysis of single-cell, spatial and bulk RNA-sequencing identifies a cell-death signature for predicting the outcomes of head and neck cancer.单细胞、空间和批量 RNA 测序的综合分析确定了一个细胞死亡特征,可用于预测头颈部癌症的结局。
Front Immunol. 2024 Nov 7;15:1487966. doi: 10.3389/fimmu.2024.1487966. eCollection 2024.
5
Cuproptosis-related gene subtypes predict prognosis in patients with head and neck squamous cell carcinoma.铜死亡相关基因亚型可预测头颈部鳞状细胞癌患者的预后。
J Otolaryngol Head Neck Surg. 2023 Sep 12;52(1):58. doi: 10.1186/s40463-023-00655-4.
姜酚酸通过抑制 Nrf2/HO-1 发挥作用诱导铁死亡,增强口腔鳞状细胞癌细胞对顺铂的敏感性。
Mol Cell Probes. 2022 Aug;64:101821. doi: 10.1016/j.mcp.2022.101821. Epub 2022 Apr 29.
4
ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity.酰基辅酶A合成酶长链家族成员4、多不饱和脂肪酸与铁死亡:抗肿瘤免疫的新武器库
Signal Transduct Target Ther. 2022 Apr 22;7(1):128. doi: 10.1038/s41392-022-01004-z.
5
Role of NRF2 in Ovarian Cancer.NRF2在卵巢癌中的作用。
Antioxidants (Basel). 2022 Mar 30;11(4):663. doi: 10.3390/antiox11040663.
6
Epithelial Membrane Protein 1 Promotes Sensitivity to RSL3-Induced Ferroptosis and Intensifies Gefitinib Resistance in Head and Neck Cancer.上皮膜蛋白 1 促进了对 RSL3 诱导的铁死亡的敏感性,并增强了头颈癌细胞对吉非替尼的耐药性。
Oxid Med Cell Longev. 2022 Apr 6;2022:4750671. doi: 10.1155/2022/4750671. eCollection 2022.
7
Non-coding RNAs and ferroptosis: potential implications for cancer therapy.非编码 RNA 与铁死亡:在癌症治疗中的潜在意义。
Cell Death Differ. 2022 Jun;29(6):1094-1106. doi: 10.1038/s41418-022-00998-x. Epub 2022 Apr 14.
8
HucMSC-derived exosomes delivered BECN1 induces ferroptosis of hepatic stellate cells via regulating the xCT/GPX4 axis.人脐带间充质干细胞来源的外泌体递送 Beclin1 通过调节 xCT/GPX4 轴诱导肝星状细胞发生铁死亡。
Cell Death Dis. 2022 Apr 8;13(4):319. doi: 10.1038/s41419-022-04764-2.
9
miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression.miRNA 引导的葡萄糖和谷氨酰胺代谢重编程及其对实体瘤进展过程中细胞黏附/迁移的影响。
Cell Mol Life Sci. 2022 Mar 29;79(4):216. doi: 10.1007/s00018-022-04228-y.
10
Targeting ferroptosis as a vulnerability in cancer.针对癌症中的铁死亡脆弱性。
Nat Rev Cancer. 2022 Jul;22(7):381-396. doi: 10.1038/s41568-022-00459-0. Epub 2022 Mar 25.